Deferred Tax Assets, Valuation Allowance of Beam Therapeutics Inc. from 31 Dec 2019 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Beam Therapeutics Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2019 to 31 Dec 2025.
  • Beam Therapeutics Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2025 was $455,329,000, a 3.9% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Beam Therapeutics Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $455,329,000 +$17,070,000 +3.9% 31 Dec 2025 10-K 24 Feb 2026 2025 FY
Q4 2024 $438,259,000 +$108,902,000 +33% 31 Dec 2024 10-K 24 Feb 2026 2025 FY
Q4 2023 $329,357,000 +$74,950,000 +29% 31 Dec 2023 10-K 25 Feb 2025 2024 FY
Q4 2022 $254,407,000 +$82,296,000 +48% 31 Dec 2022 10-K 27 Feb 2024 2023 FY
Q4 2021 $172,111,000 +$77,148,000 +81% 31 Dec 2021 10-K 28 Feb 2023 2022 FY
Q4 2020 $94,963,000 +$58,528,000 +161% 31 Dec 2020 10-K 28 Feb 2022 2021 FY
Q4 2019 $36,435,000 31 Dec 2019 10-K 15 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.